How iron can drive neurodegeneration

Boyd Kenkhuis1, Ashley I Bush2, Scott Ayton2

  • 1Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Trends in Neurosciences
|February 26, 2023
PubMed

Insights

Iron overload contributes to neurodegeneration by causing microglial ferroptosis, a cell death pathway. Ferroptosis inhibitors may offer new treatments for these debilitating brain diseases.

Area of Science:

  • Neurobiology
  • Cellular pathology
  • Neurodegenerative disease research

Background:

  • Iron accumulation is a known factor in neurodegenerative diseases.
  • The specific role of iron overload in disease mechanisms remains unclear.
  • Microglia, the brain's immune cells, are implicated in neuroinflammation and disease progression.

Purpose of the Study:

  • To investigate the specific vulnerability of microglia to iron overload.
  • To determine if iron overload induces ferroptosis in microglia.
  • To explore the therapeutic potential of targeting ferroptosis in neurodegenerative conditions.

Main Methods:

  • Analysis of microglial responses to iron overload in experimental models.
  • Examination of clinical specimens from patients with neurodegenerative diseases.
  • Assessment of cell death pathways, specifically ferroptosis.

Main Results:

  • Microglia exhibit significant vulnerability to iron overload.
  • Evidence confirms iron overload-induced ferroptosis in microglia.
  • Microglial ferroptosis was observed in human neurodegenerative disease samples.

Conclusions:

  • Microglial ferroptosis is a key mechanism linking iron overload to neurodegeneration.
  • Targeting ferroptosis pathways presents a promising therapeutic strategy.
  • Further research into ferroptosis inhibitors could yield treatments for neurodegenerative diseases.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
704
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
636
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
582
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K